Archives

RELIEVE-HF is a global, randomized, controlled, double-blinded, 500 patient pivotal study to evaluate the safety and effectiveness of V-Wave’s novel therapy. V-Wave Ltd. announced today that it [...]

$70M Series C financing led by Deerfield Management; V-Wave also announced upcoming launch of the RELIEVE-HF pivotal study. V-Wave Ltd., an Israel-based company that has developed a proprietary, [...]

Early Experience in Class III Heart Failure Patients was Favorable. V-Wave Ltd, maker of an investigational interatrial shunt device for patients with advanced heart failure (HF), announced today [...]

Funding to support further development of V-Wave’s Unidirectional Interatrial Shunt for the treatment of Heart Failure.  V-Wave Ltd. announced that it has completed a Series B financing of $28M.  [...]